• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Johns Hopkins Myositis Center

Show Search
Hide Search
  • About Myositis
    • Dermatomyositis
    • Inclusion Body Myositis
    • Juvenile Myositis
    • Polymyositis
    • Toxic Myopathies
    • Myositis Disease Education Videos
  • Our Center
    • Our Doctors
    • Our Team
    • Directions
    • Physician Referral Information
    • Preparing for an Appointment
    • In The News
  • Our Difference
    • Diagnosis of Myositis
    • Nutrition for Myositis Patients
    • Treatment of Myositis
  • Myositis Research and Clinical Trials
    • Current Research Studies
    • Recent Publications
  • Donate
    • Make a Gift
    • Peter Frampton Myositis Research Fund
Home / News / Refractory Myositis: What Can Be Done?

Refractory Myositis: What Can Be Done?

April 28, 2014 By Johns Hopkins Myositis Center

Myositis can be difficult to treat. There are no standard treatment guidelines to follow, and the disease is heterogenous. Conventional treatment consists of steroids and an immunosuppressant such as Methotrexate, Azathioprine or Mycophenolate Mofetil.  If patients continue to be symptomatic after an adequate trial of at least 3 months on therapeutic doses of these medications, this is considered refractory disease.  Other treatment strategies that can be employed in this situation are discussed in this concise article. (Registration is Required)

Receive the Latest News from Johns Hopkins Rheumatology

Receive the Latest News from Johns Hopkins Rheumatology

Join our mailing list to receive the latest news and updates from Johns Hopkins Rheumatology.

Interested In

You have Successfully Subscribed!

Filed Under: News

Johns Hopkins Myositis Center

USE OF THIS SITE

All information contained within the Johns Hopkins Rheumatology website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.

Primary Sidebar

Footer

Johns Hopkins Rheumatology

  • Johns Hopkins Rheumatology
  • Johns Hopkins Arthritis Center
  • Johns Hopkins Lupus Center
  • Johns Hopkins Lyme Disease Research Center
  • Johns Hopkins Scleroderma Center
  • Johns Hopkins Sjögren’s Syndrome Center
  • Johns Hopkins Vasculitis Center

      

Johns Hopkins Medicine

© 2025 Johns Hopkins Myositis Center
Patient Privacy